In patients with advanced PDA, the KDM8-induced gene signature is associated with reduced KRAS allelic imbalance, a feature largely driven by oncogenic KRAS amplification 39 (Figure S6F). This evidence concerns the gene KRAS and Patent ductus arteriosus.